课题基金 / 基金详情

Heat-triggered Chemotherapy to Treat Refractory Breast Cancer at the Chest Wall

Heat-triggered Chemotherapy to Treat Refractory Breast Cancer at the Chest Wall
热触发化疗治疗胸壁难治性乳腺癌
批准号：
282947
负责人：
Li Shyh-Dar
金额：
$11.66万
依托单位：
Ontario Institute for Cancer Research (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-02-01 至 2014-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=282947&lang=en
关键词：
Multidrug Resistance Platinum Drug Refractory Breast Cancer On Chest Wall Thermosensitive Liposome

项目摘要

项目成果

Li Shyh-Dar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recurrent breast cancer on chest wall is a difficult to treat disease with no standard of care. This disease occurs in 5-45% of women after mastectomy, and is often bleeding, painful, unsightly, and tedious to attend. It also creates tremendous mental dis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation and commercialization of an innovative analgesic for chronic pain
  • 批准号：
    408033
  • 项目类别：
    Operating Grants
  • 资助金额：
    $38.18万
  • 财政年份：
    2019
  • 负责人：
    Li Shyh-Dar
  • 依托单位：
    University of British Columbia
Development of child-friendly oral formulations for drugs used in the maintenance therapy of childhood acute lymphoblastic leukemia
  • 批准号：
    343659
  • 项目类别：
    Operating Grants
  • 资助金额：
    $25.06万
  • 财政年份：
    2016
  • 负责人：
    Li Shyh-Dar
  • 依托单位：
    University of British Columbia
Benchmark Cellax, a proprietary nanoparticle formulation for docetaxel, against Taxotere to treat metastatic castration resistant prostate cancer
Targeted Cancer Chemotherapy by Nanoparticle-based Drug Delivery
海外基金